| Financial Year |
March 31 2023 |
| Monetary Funds |
55,278,084,878.84 |
| Held-for-trading Financial Assets |
849,716,363.84 |
| Notes Receivable |
7,172,801,966.55 |
| Accounts Receivable |
20,036,439,030.14 |
| Advances to Suppliers |
1,171,237,123.03 |
| Other Receivables |
2,703,010,435.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
638,967,204.23 |
| Dividend Receivable |
-- |
| Inventories |
40,506,398,738.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,495,122,900.05 |
| Total Current Assets |
132,714,007,200.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
294,657,636.34 |
| Long-term Equity Investment |
24,642,288,312.74 |
| Investment Properties |
24,984,572.42 |
| Fixed Assetes |
26,979,606,450.78 |
| Under-construction Projects |
4,345,250,205.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,383,901,237.25 |
| R&D expenses |
322,987,331.53 |
| Goodwill |
23,376,070,828.05 |
| Long-Term Deferred and Prepaid Expenses |
791,770,876.32 |
| Deferred Income Tax Assets |
1,210,242,441.78 |
| Other Non-Current Assets |
1,861,654,335.48 |
| Sub-Total of Non-Current Assets |
105,365,556,007.41 |
| Total Assets |
238,079,563,208.39 |
| Short-Term Loans |
10,167,127,736.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,640,052,801.34 |
| Accounts Payable |
44,774,579,600.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,946,331,356.12 |
| Taxes Payable |
2,517,315,807.75 |
| Interest Payable |
-- |
| Dividend Payable |
1,880,719.69 |
| Other payables |
17,491,051,323.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,800,896,677.75 |
| Other Current Liabilities |
1,419,318,294.93 |
| Sub-Total of Current Liabilities |
114,049,117,488.20 |
| Long-term Loans |
17,090,550,577.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
43,076,183.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,603,317,036.96 |
| Deferred Income Tax Liabilities |
2,136,622,881.32 |
| Other Non-Current Liabilities |
113,979,429.02 |
| Sub-Total of Non-Current Liabilities |
25,885,930,257.08 |
| Total Liabilities |
139,935,047,745.28 |
| Paid-In Capital(Or Share Stock) |
9,446,598,493.00 |
| Capital Surplus |
24,090,198,258.21 |
| Surplus Reserve |
4,014,190,623.24 |
| LESS:Treasury Stock |
3,876,593,939.33 |
| Undistributed Profits |
61,923,175,990.75 |
| Minority Stockholder's Interest |
1,308,486,923.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
96,836,028,540.09 |
| Owner's Equity（Stockholder's Equity） |
98,144,515,463.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
238,079,563,208.39 |
